• Study finds high number of persistent COVID-19 infections in the general population

    Updated: 2024-02-22 20:05:06
    A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.

  • Immune Cell Receptor Provides Promising Immunotherapy Target

    Updated: 2024-02-22 16:05:33
    Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

  • Kidney cancer treatments and tumor biology can activate different immune-modifying processes in patients

    Updated: 2024-02-22 15:00:00
    The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.

  • ألوان الطيف للبول: ما هو الطبيعي وما هو غير ذلك

    Updated: 2024-02-22 13:05:49
    أوستن، ولاية مينيسوتا -- يتفاوت لون البول الطبيعي ولكنه عادةً ما يتراوح بين الشفاف والأصفر الباهت. ولكن اللون الدقيق يعتمد على كمية المياه التي تشربها، حيث تخفف السوائل من الأصباغ الصفراء في البول. فكلما أكثرت من السوائل، زادت شفافية البول. ولكن عندما تشرب كمية أقل، يصبح اللون الأصفر داكنًا أكثر.

  • New LongCOVID research launched by PolyBio's global consortium of scientists

    Updated: 2024-02-22 12:00:02
    PolyBio Research Foundation today announced the second phase of its LongCovid Research Consortium (LCRC), including the distribution of $15M to fund research and clinical trials.

  • Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds

    Updated: 2024-02-21 23:30:00
    A UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans, a group that historically has had low use of the medication.

Current Feed Items | Previous Months Items

Jan 2024 | Dec 2023 | Nov 2023 | Oct 2023 | Sep 2023 | Aug 2023